Barry Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Barry Investment Advisors's ABBV Position: Q2 2026 in Review
Barry Investment Advisors reduced its AbbVie (ABBV) stake by 2.3% in Q2 2026, selling an estimated $5.16K and leaving 1,036 shares worth $261K. The position accounts for 0.05% of the portfolio, ranked #82.
Barry Investment Advisors first reported a position in ABBV in Q2 2021 and has held it in 20 quarters since. The position peaked at $412K in Q1 2022. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Barry Investment Advisors held 1,036 shares of AbbVie worth $261K as of Q2 2026.
- Barry Investment Advisors sold 24 AbbVie shares in Q2 2026, an estimated $5.16K.
- AbbVie made up 0.05% of Barry Investment Advisors's portfolio in Q2 2026, its #82 holding.
- Barry Investment Advisors first reported a position in AbbVie in Q2 2021 and has held it in 20 quarters since.
- Barry Investment Advisors's AbbVie position peaked at $412K in Q1 2022.
- 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.